Published: February 3rd 2025 | Updated: March 4th 2025
Ocugen, Inc. receives European Medicines Agency ATMP designation for new gene therapy OCU400
Published: January 13th 2025 | Updated: February 5th 2025
Teva partners with Klinge Biopharma, Lotus Pharmaceutical for commercialisation of Formycon’s FYB203 (biosimilar aflibercept)
Published: January 31st 2024 | Updated: May 9th 2024
How biosimilars expand treatment options for patients with retinal disease
Published: September 7th 2025 | Updated: September 16th 2025
EURETINA 2025: Marion Munk, MD, PhD, discusses the IntRIS symposium
Published: September 12th 2025 | Updated: September 16th 2025
Heidelberg, STAAR, Ziemer to showcase latest technologies at ESCRS 2025
Published: September 8th 2025 | Updated: September 16th 2025
EURETINA 2025: Boris Stanzel, MD, says methotrexate is rocking the European retina landscape